Standard InChI: InChI=1S/C28H31N5O4/c1-17-28(37)33-13-7-12-24(33)27(36)32-22(14-18-8-3-2-4-9-18)26(35)31-23(25(34)30-17)15-19-16-29-21-11-6-5-10-20(19)21/h2-6,8-11,16-17,22-24,29H,7,12-15H2,1H3,(H,30,34)(H,31,35)(H,32,36)/t17-,22-,23+,24+/m0/s1
1.Dolle RE, Michaut M, Martinez-Teipel B, Seida PR, Ajello CW, Muller AL, DeHaven RN, Carroll PJ.. (2009) Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208., 19 (13):[PMID:19464172][10.1016/j.bmcl.2009.04.105]
2.Carroll FI, Carlezon WA.. (2013) Development of κ opioid receptor antagonists., 56 (6):[PMID:23360448][10.1021/jm301783x]
3.Smith MT, Kong D, Kuo A, Imam MZ, Williams CM.. (2022) Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources., 65 (3.0):[PMID:34995453][10.1021/acs.jmedchem.0c01915]